The present disclosure relates to orthopaedic prostheses and, more particularly, to tibial baseplate components in a knee prosthesis.
Orthopaedic prostheses are commonly utilized to repair and/or replace damaged bone and tissue in the human body. For a damaged knee, a knee prosthesis may be implanted using a proximal tibial baseplate component, a tibial bearing component, and a distal femoral component. The tibial baseplate component is affixed to a proximal end of the patient's tibia, which is typically resected to accept the baseplate component. The femoral component is implanted on a distal end of the patient's femur, which is also typically resected to accept the femoral component. The tibial bearing component is placed between the tibial baseplate component and the femoral component, and may be fixed or slidably coupled to the tibial baseplate component.
The tibial baseplate component provides support for the tibial bearing component. Forces generated by use of the knee prosthesis are transferred through the tibial bearing component to the tibial baseplate component, and ultimately to the tibia. In order to ensure long term performance of the knee prosthesis, stable and firm securement of the tibial baseplate component to the proximal end of the patient's tibia is desired.
This application is related to U.S. Provisional Patent Application Ser. No. 61/562,133, filed Nov. 21, 2011, to U.S. Provisional Patent Application Ser. No. 61/592,571, filed Jan. 30, 2012, and to U.S. Provisional Patent Application Ser. No. 61/594,030, filed Feb. 2, 2012, the entire disclosures of which are hereby expressly incorporated by reference herein.
The present disclosure provides an orthopaedic knee prosthesis including a tibial baseplate component having a distal, bone-contacting surface with one or more fixation structures extending distally therefrom, the fixation structures being asymmetrically arranged within the outer periphery of the baseplate.
For designs utilizing a plurality of fixation pegs that extend distally from the bone-contacting surface of the tibial baseplate, fixation pegs are asymmetrically arranged in opposite anterior/lateral and posterior/medial regions of the tibial baseplate, thereby maximizing distance between the fixation pegs, avoiding overlap with the intramedullary canal, avoiding areas of low bone density, and avoiding cortical impingement by positioning the fixation pegs in regions of cancellous bone.
For designs utilizing a single keel that extends distally from the bone-contacting surface of the tibial baseplate, the keel is medialized with respect to the outer periphery of the tibial baseplate, where the degree of medialization increases as prosthesis sizes grow progressively.
According to an embodiment thereof, the present disclosure provides a tibial prosthesis system comprising: a first tibial baseplate comprising: a first proximal surface; a first distal surface opposite the first proximal surface, the first distal surface sized and shaped to substantially cover a proximal resected surface of a tibia; a first medial face; a first lateral face opposite the first medial face; a first total width measured from the first medial face to the first lateral face; and a first keel extending distally from the first distal surface, the first keel spaced from the first medial face by a first medial distance and spaced apart from the first lateral face by a first lateral distance; and a second tibial baseplate comprising: a second proximal surface; a second distal surface opposite the second proximal surface, the second distal surface sized and shaped to substantially cover a proximal resected surface of a tibia; a second medial face; a second lateral face opposite the second medial face; a second total width measured between the second medial face and the second lateral face, the second total width differing from the first total width whereby the first and second tibial baseplates comprise unique nominal sizes; and a second keel extending distally from the second distal surface, the second keel spaced apart from the second medial face by a second medial distance and spaced apart from the second lateral face by a second lateral distance, a first ratio of the first medial distance to the first total width differing from a second ratio of the second medial distance to the second total width.
According to another embodiment thereof, the present disclosure provides a tibial baseplate configured for implantation upon a patient's proximal tibia, the tibial baseplate comprising: a medial compartment; a lateral compartment opposite the medial compartment; a proximal surface; a distal surface opposite the proximal surface, the distal surface sized and shaped to substantially cover the patient's proximal tibia; an outer periphery cooperatively defined by an anterior face, a medial face, a lateral face, and at least one posterior face; a first, anterior-posterior axis located between the medial face and the lateral face and intersecting the anterior face, the first axis extending centrally between the medial and lateral compartments throughout its length; a plurality of fixation pegs extending distally from the distal surface, each of the plurality of fixation pegs being positioned inward of the outer periphery for implantation into the patient's proximal tibia, the plurality of fixation pegs comprising: a medial fixation peg located at the medial compartment; and a lateral fixation peg located at the lateral compartment, the lateral fixation peg being positioned more anteriorly than each other fixation peg among the plurality of fixation pegs.
According to yet another embodiment thereof, the present disclosure provides a tibial baseplate configured for implantation upon a patient's proximal tibia, the tibial baseplate comprising: a medial compartment; a lateral compartment opposite the medial compartment; a proximal surface; a distal surface opposite the proximal surface, the distal surface sized and shaped to substantially cover the patient's proximal tibia; an outer periphery cooperatively defined by an anterior face, a medial face, a lateral face, and at least one posterior face; at most one medial fixation peg associated with the medial compartment, the medial fixation peg extending distally from the distal surface and positioned for implantation into the patient's proximal tibia; and at most one lateral fixation peg associated with the lateral compartment, the lateral fixation peg extending distally from the distal surface and positioned for implantation into the patient's proximal tibia, the lateral fixation peg being located closer to the anterior face than the medial fixation peg.
According to still another embodiment thereof, the present disclosure provides a tibial baseplate configured for implantation upon a patient's proximal tibia, the tibial baseplate comprising: a medial compartment; a lateral compartment opposite the medial compartment; a proximal surface; a distal surface opposite the proximal surface, the distal surface sized and shaped to substantially cover the patient's proximal tibia; an outer periphery cooperatively defined by an anterior face, a medial face, a lateral face, and at least one posterior face; a first, anterior-posterior axis located between the medial face and the lateral face and intersecting the anterior face, the first axis extending centrally between the medial and lateral compartments throughout its length; a first fixation peg extending distally from the distal surface, the first fixation peg being inset from the outer periphery for implantation into the patient's proximal tibia, the first fixation peg being medially spaced from the first axis by a first distance; and a second fixation peg extending distally from the distal surface, the second fixation peg being inset from the outer periphery for implantation into the patient's proximal tibia, the second fixation peg being laterally spaced from the first axis by a second distance, the second distance less than the first distance.
The above-mentioned and other features and advantages of this disclosure, and the manner of attaining them, will become more apparent and the invention itself will be better understood by reference to the following description of embodiments of the invention taken in conjunction with the accompanying drawings, wherein:
Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate exemplary embodiments of the invention and such exemplifications are not to be construed as limiting the scope of the invention in any manner.
The present disclosure provides a tibial baseplate component for a knee prosthesis including asymmetrically arranged distal fixation structures which promote secure and stable long term fixation of the tibial baseplate to a patient's proximal tibia.
In order to prepare the tibia and femur for receipt of a knee joint prosthesis of the present disclosure, any suitable methods or apparatuses for preparation of the knee joint may be used. The surgical procedure may involve, for example, forming an incision in the patient's skin near the knee joint, resecting the distal end of the patient's femur (not shown), and resecting the proximal end of the patient's tibia T (
Exemplary surgical procedures and associated surgical instruments are disclosed in Zimmer's “LPS-Flex Fixed Bearing Knee, Surgical Technique” bearing copyright dates of 2004, 2007 and 2008, “NexGen® Complete Knee Solution, Surgical Technique for the CR-Flex Fixed Bearing Knee” bearing a copyright date of 2003, “NexGen® Complete Knee Solution Extramedullary/Intramedullary Tibial Resector, Surgical Technique” bearing copyright dates of 2000, 2008 and 2009, “NexGen® Trabecular Metal™ Monoblock Tibial Components, Surgical Technique Addendum,” bearing copyright dates of 2005 and 2007, “NexGen® Trabecular Metal™ Tibial Tray, Surgical Technique,” bearing copyright dates of 2007 and 2009, and “Trabecular Metal™ Monoblock Tibial Components,” bearing a copyright date of 2007 (collectively, the “Zimmer Surgical Techniques”), the entire disclosures of which are hereby expressly incorporated herein by reference, copies of which are submitted on even date herewith in an Information Disclosure Statement.
As used herein, “proximal” refers to a direction generally toward the torso of a patient, and “distal” refers to the opposite direction of proximal (i.e., away from the torso of a patient). “Anterior” refers to a direction generally toward the front of a patient or knee, and “posterior” refers to the opposite direction of anterior (i.e., toward the back of the patient or knee). “Lateral” refers to a direction generally away from the middle of the patient and the sagittal plane, and “medial” refers to the opposite direction of lateral (i.e., toward the middle of the patient and the sagittal plane). When referring to one of the patient's knees, “lateral” refers to the direction generally away from the other knee, and “medial” refers to the direction generally toward the other knee.
These anatomical regions are labeled in certain drawings for clarity. In
The embodiments shown and described herein illustrate components for a right knee prosthesis. Right and left knee prosthesis configurations are generally mirror images of one another about a sagittal plane. Thus, it will be appreciated that the aspects of the prosthesis described herein for a right knee configuration are equally applicable to a left knee configuration.
1. Tibial Baseplate
Referring now to
Baseplate 10 may be partially or entirely constructed of a highly porous biomaterial. A highly porous biomaterial is useful as a bone substitute and as cell and tissue receptive material. A highly porous biomaterial may have a porosity as low as 55%, 65%, or 75% or as high as 80%, 85%, or 90%. An example of such a material is produced using Trabecular Metal™ Technology generally available from Zimmer, Inc., of Warsaw, Ind. Trabecular Metal™ is a trademark of Zimmer, Inc. Such a material may be formed from a reticulated vitreous carbon foam substrate which is infiltrated and coated with a biocompatible metal, such as tantalum, by a chemical vapor deposition (“CVD”) process in the manner disclosed in detail in U.S. Pat. No. 5,282,861 to Kaplan, the entire disclosure of which is expressly incorporated herein by reference. In addition to tantalum, other metals such as niobium, or alloys of tantalum and niobium with one another or with other metals may also be used.
Generally, the porous tantalum structure includes a large plurality of ligaments defining open spaces therebetween, with each ligament generally including a carbon core covered by a thin film of metal such as tantalum, for example. The open spaces between the ligaments form a matrix of continuous channels having no dead ends, such that growth of cancellous bone through the porous tantalum structure is uninhibited. The porous tantalum may include up to 75%, 85%, or more void space therein. Thus, porous tantalum is a lightweight, strong porous structure which is substantially uniform and consistent in composition, and closely resembles the structure of natural cancellous bone, thereby providing a matrix into which cancellous bone may grow to provide fixation of baseplate 10 to the patient's bone.
The porous tantalum structure may be made in a variety of densities in order to selectively tailor the structure for particular applications. In particular, as discussed in the above-incorporated U.S. Pat. No. 5,282,861, the porous tantalum may be fabricated to virtually any desired porosity and pore size, and can thus be matched with the surrounding natural bone in order to provide an improved matrix for bone ingrowth and mineralization.
Bearing component 53 may be molded directly onto baseplate 10, specifically proximal surface 11 of baseplate 10. If baseplate 10 is constructed of a highly porous biomaterial, as discussed above, the material that is used to construct bearing component 53 (e.g., polyethylene) may interdigitate into the pores of baseplate 10 during the molding process. The pores may be located at and beneath proximal surface 11 of baseplate 10, so the resulting molded bearing component 53 may also be located at and beneath proximal surface 11 of baseplate 10. The resulting structure may be a monoblock component having a strong, wear-resistant connection between baseplate 10 and bearing component 53, especially along proximal surface 11 of baseplate 10.
Baseplate 10 includes outer periphery 12, which may be visible in a top plan view (
Baseplate 10 also includes lateral compartment 14, medial compartment 16, and interior compartment 17 therebetween. Lateral compartment 14 and medial compartment 16 are separated by an anterior-posterior home axis AH, which is discussed further below. Because
With bearing component 53 in place against baseplate 10 (
Anterior face 18 of the illustrative baseplate 10 is disposed anteriorly on periphery 12 of baseplate 10 (i.e., in the A region of tibia T). Anterior face 18 is generally centrally located between lateral and medial compartments 14, 16. More specifically, as shown in
Posterior/lateral face 20 of the illustrative baseplate 10 is disposed generally opposite anterior face 18 in the posterior region of lateral compartment 14 (i.e., near the PL region of tibia T). Posterior/medial face 22 of the illustrative baseplate 10 is disposed generally opposite anterior face 18 in the posterior region of medial compartment 16 (i.e., near the PM region of tibia T). The PCL cutout area 24 is disposed between posterior/lateral face 20 and posterior/medial face 22 (i.e., near the P region of tibia T). From both posterior/lateral face 20 and posterior/medial face 22, the PCL cutout area 24 extends generally anteriorly until reaching apex 24a.
Lateral face 62 of the illustrative baseplate 10 is disposed laterally of lateral compartment 14 on periphery 12 of baseplate 10 (i.e., near the L region of tibia T). Medial face 60 of the illustrative baseplate 10 is located medially of medial compartment 16 on periphery 12 of baseplate 10 (i.e., near the M region of tibia T).
2. Home Axis and Other Reference Axes of Tibial Baseplate
In the context of patient anatomy, such as tibia T described herein, “home axis” AH of tibia T extends anteriorly from a posterior point PP on tibia T to an anterior point PA on tibia T. The posterior point PP and the anterior point PA of tibia T are discussed further below.
The posterior point PP is generally disposed in the area where the patient's posterior cruciate ligament (PCL) attaches to tibia T. More specifically, the posterior point PP is generally disposed at the geometric center of the attachment between the patient's PCL and tibia T. The patient's PCL typically attaches to tibia T in two ligament “bundles,” the first bundle having a more anterolateral attachment location and the second bundle having a more posteromedial attachment location. In
The anterior point PA is disposed on the patient's anterior tibial tubercle B. In
In the context of a prosthesis, such as tibial baseplate 10 described herein, “home axis” AH of baseplate 10 refers to an anterior-posterior extending axis of baseplate 10 that aligns with home axis AH of tibia T upon implantation of baseplate 10 onto resected surface S of tibia T in a proper rotational and spatial orientation (as shown in
In the illustrative embodiment of
The home axes AH of tibia T and baseplate 10 are further described in U.S. Patent Application Publication No. 2012/0022659, filed Jul. 22, 2011, entitled “ASYMMETRIC TIBIAL COMPONENTS FOR A KNEE PROSTHESIS,” the entire disclosure of which is hereby expressly incorporated herein by reference.
A pair of reference axes 26, 28 is presented in
The first and second reference axes 26, 28 illustratively intersect one another and home axis AH at a common point X within periphery 12 of baseplate 10. According to an exemplary embodiment of the present disclosure, point X is generally centered within periphery 12 of baseplate 10 to maximize the aggregated extent of each reference axis 26, 28 that is located within periphery 12 of baseplate 10 while maintaining the desired first and second angles α and β, as discussed above. Point X is illustratively positioned along home axis AH between flat portion 18a of anterior face 18 and apex 24a of PCL cutout area 24.
Illustratively, a medial-lateral axis 50 also extends through point X in a direction perpendicular to home axis AH. Together, the medial-lateral axis 50 (e.g., the x-axis) and the anterior-posterior home axis AH (e.g., the y-axis) cooperate to define a component coordinate system (e.g., an x-y coordinate system) useful for quantifying and identifying certain features of baseplate 10.
3. Shape of Outer Periphery of Tibial Baseplate
According to an exemplary embodiment of the present disclosure, and as shown in
The asymmetric shape of baseplate 10 is further described in U.S. Patent Application Publication No. 2012/0022659, filed Jul. 22, 2011, entitled “ASYMMETRIC TIBIAL COMPONENTS FOR A KNEE PROSTHESIS,” the entire disclosure of which is hereby expressly incorporated herein by reference.
It is also within the scope of the present disclosure that baseplate 10 may have a symmetric outer periphery 212, as shown in phantom in
4. Fixation Pegs
Referring next to
Each fixation peg 30, 32 is inset from outer periphery 12 of baseplate 10. Each fixation peg 30, 32 may have a minimum inset distance 39 (
According to an exemplary embodiment of the present disclosure, fixation pegs 30, 32 of baseplate 10 are constructed of a highly porous biomaterial, such as the above-described porous tantalum material. Distal surface 34 of baseplate 10 may also be constructed of a highly porous biomaterial. With distal surface 34 of baseplate 10 resting against resected surface S of tibia T and fixation pegs 30, 32 of baseplate 10 extending distally into tibia T, the highly porous biomaterial may provide a matrix into which cancellous bone may grow to provide fixation of baseplate 10 to tibia T.
As shown in
According to an exemplary embodiment of the present disclosure, and as discussed further below, lateral and medial fixation pegs 30, 32 are asymmetrically arranged on distal surface 34 of baseplate 10. In one exemplary embodiment, fixation pegs 30, 32 are asymmetrically arranged about the anterior-posterior home axis AH, such that the anterior-posterior home axis AH is not an axis of symmetry of fixation pegs 30, 32. In another embodiment, fixation pegs 30, 32 are asymmetrically arranged about the medial-lateral axis 50, such that the medial-lateral axis 50 is not an axis of symmetry of fixation pegs 30, 32. In yet another embodiment, fixation pegs 30, 32 are asymmetrically arranged about both the anterior-posterior home axis AH and the medial-lateral axis 50, such that neither the anterior-posterior home axis AH nor the medial-lateral axis 50 is an axis of symmetry of fixation pegs 30, 32.
5. Anterior/Lateral (AL) and Posterior/Medial (PM) Positioning of Fixation Pegs
Returning now to
In the medial compartment 16 of baseplate 10, medial fixation peg 32 is positioned posteriorly relative to the medial-lateral axis 50 and posteriorly of lateral fixation peg 30. Thus, medial fixation peg 32 is more generally positioned in the PM region of tibia T while being substantially distanced from the AM region of tibia T. The PM bias of medial fixation peg 32 is evident in
An alternative baseplate 10′ is shown in
Another alternative baseplate 10″ is shown in
Returning again to
Also, the asymmetric arrangement of lateral and medial fixation pegs 30, 32 on opposite sides of the medial-lateral axis 50 may enhance the torsional stability of baseplate 10 when implanted upon tibia T (
Furthermore, positioning lateral and medial fixation pegs 30, 32 in the AL and PM regions of tibia T, rather than the PL and AM regions of tibia T, may avoid impingement of pegs 30, 32 on adjacent cortical bone upon implantation of baseplate 10. Advantageously, the AL and PM regions of tibia T (where fixation pegs 30, 32 are located) are typically populated with substantial areas of cancellous bone, thereby promoting firm and stable long-term fixation of tibial baseplate 10 to tibia T and promoting bone ingrowth. By contrast, the PL and AM regions of tibia T (where fixation pegs 30, 32 are not located) are typically populated with substantial areas of cortical bone. By avoiding the PL and AM regions of tibia T, the potential for impingement of fixation pegs 30, 32 upon cortical bone is minimized.
6. Lateral/Medial Positioning of Fixation Pegs
Because lateral fixation peg 30 extends from lateral compartment 14 and medial fixation peg 32 extends from medial compartment 16, as discussed above, lateral fixation peg 30 can be said to be positioned “more laterally” on distal surface 34 of baseplate 10 than medial fixation peg 32. Similarly, medial fixation peg 32 is positioned “more medially” on distal surface 34 of baseplate 10 than lateral fixation peg 30. Thus, as shown in
According to an exemplary embodiment of the present disclosure, lateral fixation peg 30 and/or medial fixation peg 32 are medially biased in their respective compartments 14, 16. In lateral compartment 14, the illustrative lateral fixation peg 30 is medially biased toward home axis AH. In medial compartment 16, the illustrative medial fixation peg 32 is medially biased away from home axis AH. The medial bias of fixation pegs 30, 32, is evident in
If fixation pegs 30, 32 were equally spaced apart from home axis AH, central peg axis 38 would coincide with home axis AH. However, in
7. Anterior/Posterior Positioning of Fixation Pegs
As discussed above, lateral fixation peg 30 is positioned relatively more anteriorly on distal surface 34 of baseplate 10 than medial fixation peg 32. Stated differently, medial fixation peg 32 is positioned relatively more posteriorly on distal surface 34 of baseplate 10 than lateral fixation peg 30. Thus, as shown in
The alternative baseplates 10′, 10″ of
Turning now to
The alternative baseplates 10′, 10″ of
8. Asymmetric Positioning of Fixation Pegs for Set of Prostheses
Baseplate 10 may be provided in a kit or set of different prosthesis sizes. In one embodiment, nine baseplates 10 are provided in the set, with baseplates 10 growing progressively in lateral anterior/posterior depth 44 and/or other dimensions, for example. The progressive growth of periphery 12 of baseplates 10 across the set or family of baseplate sizes is described in detail in U.S. Patent Application Publication No. 2012/0022660 filed Jul. 22, 2011 and entitled ASYMMETRIC TIBIAL COMPONENTS FOR A KNEE PROSTHESIS, the entire disclosure of which is hereby expressly incorporated herein by reference.
Referring next to
For each given prosthesis size (i.e., each discrete value of lateral depth 44), a pair of points are presented for lateral and medial peg distances 46, 48, respectively, with a space between the pair of points. This space indicates that peg distances 46, 48 are different for each of the nine given prosthesis sizes. Medial peg distances 48 consistently exceed the corresponding lateral peg distances 46 for each of the nine given prosthesis sizes. For example, each medial peg distance 48 may exceed the corresponding lateral peg distance 46 by 7 mm to 11 mm. In this manner, each of the given prostheses has anterior/posterior asymmetry of fixation pegs 30, 32 with respect to anterior face 18.
With respect to the alternative baseplate 10′ of
According to an exemplary embodiment of the present disclosure, the above-described distances, including inset distance 39, medial-lateral separation distance 36, offset distance 40, anterior-posterior separation distance 42, lateral peg distance 46, and medial peg distance 48, are measured along distal surface 34 of baseplate 10. As a result, the distances are measured near the intersection of each peg 30, 32 with distal surface 34 (e.g., near the proximal end of each peg 30, 32). In embodiments where pegs 30, 32 are perpendicular to distal surface 34, the distances could also be measured away from distal surface 34 (e.g., near the distal end of each peg 30, 32) without impacting the measurements. In embodiments where pegs 30, 32 are canted relative to distal surface 34, however, the measurements could vary if taken away from distal surface 34 (e.g., near the distal end of each canted peg 30, 32). Therefore, for consistency, the measurements are taken along distal surface 34 of baseplate 10.
9. Force Testing of Asymmetric Fixation Pegs
A first prosthesis was manufactured, as shown in
The illustrative bearing component 53 has lateral articular surface 54, medial articular surface 56, and spine 58 located therebetween. When bearing component 53 is assembled onto baseplate 10, as shown in
As shown in
Simultaneously with application of the compressive force FCL, FCM, an anterior-facing force FAP was applied to the distal/posterior base of spine 58,as shown in
Forces FCL, FCM, and FAP were designed in magnitude and area of application to replicate forces exerted on tibial bearing component 53 by a prosthetic femoral component, e.g., femoral component 70, during a kneeling motion. An exemplary femoral component which articulates with tibial bearing component 53 is described in U.S. Provisional Patent Application Ser. No. 61/561,658, filed Nov. 18, 2011, and is further described in U.S. Provisional Patent Application Ser. No. 61/579,873, filed Dec. 23, 2011, and is further described in U.S. Provisional Patent Application Ser. No. 61/592,575, filed on Jan. 30, 2012, and is further described in U.S. Provisional Patent Application Ser. No. 61/594,113 filed on Feb. 2, 2012, and is further described in U.S. Provisional Patent Application Ser. No. 61/621,370 filed Apr. 6, 2012, and are further described in U.S. Provisional Patent Application Ser. No. 61/621,372 filed Apr. 6, 2012, and are further described in U.S. Provisional Patent Application Ser. No. 61/621,373filed Apr. 6, 2012, and are further described in U.S. patent application Ser. No. 13/459,061filed Apr. 27, 2012, and are further described in U.S. patent application Ser. No. 13/459,064 filed Apr. 27, 2012, and are further described in U.S. patent application Ser. No. 13/459,060 filed Apr. 27, 2012, all entitled “FEMORAL COMPONENT FOR A KNEE PROSTHESIS WITH IMPROVED ARTICULAR CHARACTERISTICS,” the entire disclosures of which are hereby expressly incorporated herein by reference.
Finite element analysis was performed on the first, second, and third prostheses to evaluate and compare stresses experienced at the interface of baseplates 10, 10′, 10″ and a simulated tibial bone that was well fixed to each respective baseplate. Peak stresses experienced in the above-described loading scenario were substantially reduced for the first baseplate 10 having asymmetrically arranged fixation pegs 30, 32 as compared to the second baseplate 10′ having aligned fixation pegs 30′, 32′ and the third baseplate 10″ having aligned fixation pegs 30″, 32″. More particularly, a 51% reduction in peak stress was observed in the first baseplate 10 as compared to the second baseplate 10′, and a 46% reduction in peak stress was observed in the first baseplate 10 as compared to the third baseplate 10″.
10. Additional Fixation Pegs
In addition to lateral fixation peg 30 described above, lateral compartment 14 of tibial baseplate 100 may further include at least one additional lateral fixation peg 330. As shown in
In addition to medial fixation peg 32 described above, medial compartment 16 of tibial baseplate 100 may further include at least one additional medial fixation peg 332. As shown in
11. Fixation Keel
Turning to
The illustrative keel 130 of
Keel fins 133 also define keel fin angle γ with respect to longitudinal axis AK of cylindrical core 131 of keel 130. In an exemplary embodiment, keel angle γ is equal to between 22 degrees and 27 degrees. Keel fin angle γ and longitudinal extent longitudinal extent PDK of cylindrical core 131 cooperate to define a medial/lateral keel extent MLK (
In an exemplary embodiment, keel 130 defines a substantially cylindrical outer profile as illustrated in
Prior art tibial baseplates include constant-diameter keels in this diameter range, such as the Zimmer NexGen Stemmed Tibial Plates and Natural Knee II Modular Cemented Tibial Plates. The NexGen Stemmed Tibial Plates and Natural Knee II Modular Cemented Tibial Plates are shown at pages 14 and 28, respectively, of the “Zimmer® Tibial Baseplate, Pocket Guide United States Version,” the entire disclosure of which is hereby expressly incorporated herein by reference, a copy of which is submitted on even date herewith in an Information Disclosure Statement.
In
As discussed above, fixation pegs 30, 32 of baseplate 10 (
Although keel 130 may be the only fixation structure on baseplate 100, it is also within the scope of the present disclosure to combine keel 130 with additional fixation structures. In one embodiment, keel 130 may be combined with the above-described fixation pegs 30, 32 (
Keel 130 may also include a tapered bore (not shown) extending proximally into the distal tip of keel 130, designed to mate with a corresponding locking-taper surface of a tibial stem extension.
12. Lateral/Medial Positioning of Fixation Keel
As shown in
According to an exemplary embodiment of the present disclosure, offset distance 163 is measured along distal surface 134 of baseplate 100. As a result, offset distance 163 is measured medially from the intersection of home axis AH and distal surface 134 to the intersection of keel axis AK and distal surface 134 (e.g., near the proximal end of keel 130). In embodiments where keel axis AK is perpendicular to distal surface 134, offset distance 163 could also be measured away from distal surface 134 (e.g., near the distal end of keel 130) without impacting the measurement. In embodiments where keel axis AK is canted relative to distal surface 134, however, the measurement could vary if taken away from distal surface 134 (e.g., near the distal end of the canted keel 130). Therefore, for consistency, the measurement is taken along distal surface 134 of baseplate 100.
In embodiments where baseplate 100 has a symmetric outer periphery 112, an anterior-posterior axis of symmetry through outer periphery 112 may be used as a “home axis” AH for referencing medial face 160, lateral face 162, keel 130, and other components of baseplate 100. This home axis AH would be substantially centered between medial face 160 and lateral face 162. With keel axis AK being medially offset from the central home axis AH, keel axis AK would be positioned closer to medial face 160 than lateral face 162. Thus, medial distance 164 between keel axis AK and the medial-most portion of medial face 160 would be less than lateral distance 166 between keel axis AK and the lateral-most portion of lateral face 162.
In embodiments where baseplate 100 has an asymmetric outer periphery 112, as shown in
The degree of medialization of keel 130 may be expressed as a ratio or a percentage and may be calculated by dividing the offset distance 163 between keel axis AK and home axis AH by the total medial/lateral width of distal surface 134 (i.e., medial distance 164 plus lateral distance 166). For baseplate 100 having the dimensions set forth in Table 1 below, for example, the degree of medialization would be approximately 6% (calculated as 5 mm/88 mm×100%).
Advantageously, the medial bias of keel 130 (i.e., the relatively short medial distance 164 and the relatively long lateral distance 166) more closely aligns keel 130 with the intramedullary canal of the patient's tibia T (
13. Lateral/Medial Positioning of Fixation Keel for Set of Prostheses
Baseplate 100 may be provided in a kit or set of different prosthesis sizes. In one embodiment, nine nominal sizes of baseplate 100 are provided in the set, with baseplates 100 growing progressively in size.
According to an exemplary embodiment of the present disclosure, the degree of medialization of keel 130 increases as the prostheses in the set grow in size. Thus, rather than maintaining a fixed relationship between medial distance 164 and lateral distance 166 as the prostheses grow in size, medial distance 164 makes up a smaller and smaller portion of the total width as the prostheses grow in size, and lateral distance 166 makes up a larger and larger portion of the total width as the prostheses grow in size. Stated differently, the rate at which keel 130 moves toward medial face 160 exceeds that rate at which the prostheses grow in size.
The dimensions of another sample baseplate 100 are provided in Table 2 below. Baseplate 100 of Table 2, which has a total width of 58 mm, is smaller than baseplate 100 of Table 1 above, which has a total width of 88 mm.
As baseplates 100 of the present set grow in size from Table 2 to Table 1 (i.e., from a small nominal size having a 58 mm total width to a large nominal size having an 88 mm total width), the degree of medialization of keel 130 increases relative to home axis AH (from 2% to 6%). Also, as keel 130 moves medially from the small size of Table 2 to the large size of Table 1, medial distance 164 makes up a smaller portion of the total width (from 50% to 47%), and lateral distance 166 makes up a larger portion of the total width (from 50% to 53%).
Advantageously, increasing the degree of medialization of keel 130 as baseplate 100 grows in size may better track the position of the intramedullary canal as the patient's tibia T (
The increasing medialization of keel 130 is presented graphically in
In a smaller bone, the metaphyseal region of tibia T is more closely aligned with the diaphyseal region of tibia T. Therefore, keel 130 may achieve an optimum metaphyseal and diaphyseal fit with a relatively small offset distance 163 (e.g., 1 mm, 2 mm). In a larger bone, by contrast, the metaphyseal region of tibia T is more offset from the diaphyseal region of tibia T. Therefore, keel 130 may require a relatively large offset distance 163 (e.g., 4 mm, 5 mm) to achieve an optimum metaphyseal and diaphyseal fit.
As discussed above, the degree of medialization of keel 130 may be expressed as a percentage by dividing the offset distance 163 between keel axis AK and home axis AH by the total medial/lateral width. In
14. Anterior/Posterior Positioning of Fixation Keel for Set of Prostheses
As shown in
According to an exemplary embodiment of the present disclosure, keel distance 147 is measured along distal surface 134 of baseplate 100. As a result, keel distance 147 is measured posteriorly from the intersection of flat portion 118a of anterior face 118 and distal surface 134 to the intersection of keel axis AK and distal surface 134 (e.g., near the proximal end of keel 130). In embodiments where keel axis AK is perpendicular to distal surface 134, keel distance 147 could also be measured away from distal surface 134 (e.g., near the distal end of keel 130) without impacting the measurement. In embodiments where keel axis AK is canted relative to distal surface 134, however, the measurement could vary if taken away from distal surface 134 (e.g., near the distal end of the canted keel 130). Therefore, for consistency, the measurement is taken along distal surface 134 of baseplate 100.
Across a set of different tibial baseplates 100 having varying nominal sizes, the anterior/posterior positioning of keel 130 may vary. In
15. Proximal Keel Expansion
As shown in
The illustrative bore 180 of
As keel 130 becomes more and more offset from home axis AH and bore 180, bulge 182 may become larger and larger in size. For example, for medium nominal prosthesis sizes (e.g., sizes 5 and 6) having medium offset distances 163 between keel axis AK and home axis AH (e.g., 3 mm), bulge 182 may increase the diameter of keel 130 by 0.5 mm. For large nominal prosthesis sizes (e.g., sizes 7-9) having large offset distances 163 between keel axis AK and home axis AH (e.g., 4 mm, 5 mm), bulge 182 may increase the diameter of keel 130 by 1.4 mm. For small nominal prosthesis sizes (e.g., sizes 1-4) having small offset distances 163 between keel axis AK and home axis AH (e.g., 1 mm, 2 mm), bulge 182 may be excluded.
While this invention has been described as having exemplary designs, the present invention can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains and which fall within the limits of the appended claims.
This application is a continuation of U.S. patent application Ser. No. 13/593,339 filed on Aug. 23, 2012, which claims the benefit under Title 35 U.S.C. §119(e) of U.S. Provisional Patent Application Ser. No. 61/562,133 filed Nov. 21, 2011, U.S. Provisional Patent Application Ser. No. 61/592,571 filed Jan. 30, 2012, U.S. Provisional Patent Application Ser. No. 61/594,030 filed Feb. 2, 2012, and U.S. Provisional Patent Application Ser. No. 61/621,369 filed Apr. 6, 2012, each entitled TIBIAL BASEPLATE WITH ASYMMETRIC PLACEMENT OF FIXATION STRUCTURES and U.S. Provisional Patent Application Ser. No. 61/592,574 filed Jan. 30, 2012 and U.S. Provisional Patent Application Ser. No. 61/621,374 filed Apr. 6, 2012, both entitled ASYMMETRIC TIBIAL COMPONENTS FOR A KNEE PROSTHESIS. The entire disclosures of all of the above-identified patent applications are hereby expressly incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
4016606 | Murray et al. | Apr 1977 | A |
4340978 | Buechel et al. | Jul 1982 | A |
4714474 | Brooks, Jr. et al. | Dec 1987 | A |
4769040 | Wevers | Sep 1988 | A |
4770661 | Oh | Sep 1988 | A |
4795468 | Hodorek et al. | Jan 1989 | A |
4822365 | Walker et al. | Apr 1989 | A |
4936853 | Fabian et al. | Jun 1990 | A |
4950298 | Gustilo et al. | Aug 1990 | A |
4959071 | Brown et al. | Sep 1990 | A |
4963152 | Hofmann et al. | Oct 1990 | A |
5047058 | Roberts et al. | Sep 1991 | A |
5061271 | Van Zile | Oct 1991 | A |
5071438 | Jones et al. | Dec 1991 | A |
5133758 | Hollister | Jul 1992 | A |
5137536 | Koshino | Aug 1992 | A |
5192328 | Winters | Mar 1993 | A |
5219362 | Tuke et al. | Jun 1993 | A |
5236461 | Forte | Aug 1993 | A |
5246459 | Elias | Sep 1993 | A |
5271737 | Baldwin et al. | Dec 1993 | A |
5282861 | Kaplan | Feb 1994 | A |
5282868 | Bahler | Feb 1994 | A |
5282870 | Moser et al. | Feb 1994 | A |
5290313 | Heldreth | Mar 1994 | A |
5310480 | Vidueira | May 1994 | A |
5326361 | Hollister | Jul 1994 | A |
5344460 | Turanyi et al. | Sep 1994 | A |
5370699 | Hood et al. | Dec 1994 | A |
5405396 | Heldreth et al. | Apr 1995 | A |
5413604 | Hodge | May 1995 | A |
5413605 | Ashby et al. | May 1995 | A |
5489311 | Cipolletti | Feb 1996 | A |
5507820 | Pappas | Apr 1996 | A |
5549688 | Ries et al. | Aug 1996 | A |
5556433 | Gabriel et al. | Sep 1996 | A |
5609639 | Walker | Mar 1997 | A |
5609641 | Johnson et al. | Mar 1997 | A |
5609645 | Vinciguerra | Mar 1997 | A |
5613970 | Houston et al. | Mar 1997 | A |
5658344 | Hurlburt | Aug 1997 | A |
5683470 | Johnson et al. | Nov 1997 | A |
5702463 | Pothier et al. | Dec 1997 | A |
5755801 | Walker et al. | May 1998 | A |
5755802 | Gerber | May 1998 | A |
5824100 | Kester et al. | Oct 1998 | A |
5824102 | Buscayret | Oct 1998 | A |
5871539 | Pappas | Feb 1999 | A |
5879394 | Ashby et al. | Mar 1999 | A |
5928286 | Ashby et al. | Jul 1999 | A |
5964808 | Blaha et al. | Oct 1999 | A |
6004351 | Tomita et al. | Dec 1999 | A |
6010534 | O'neil et al. | Jan 2000 | A |
6013103 | Kaufman et al. | Jan 2000 | A |
6039764 | Pottenger et al. | Mar 2000 | A |
6068658 | Insall et al. | May 2000 | A |
6074425 | Pappas | Jun 2000 | A |
6090144 | Letot et al. | Jul 2000 | A |
6102954 | Albrektsson et al. | Aug 2000 | A |
6102955 | Mendes et al. | Aug 2000 | A |
6197064 | Haines et al. | Mar 2001 | B1 |
6203576 | Afriat et al. | Mar 2001 | B1 |
6206927 | Fell et al. | Mar 2001 | B1 |
RE37277 | Baldwin et al. | Jul 2001 | E |
6258127 | Schmotzer | Jul 2001 | B1 |
6306172 | O'Neil et al. | Oct 2001 | B1 |
6379388 | Ensign et al. | Apr 2002 | B1 |
6413279 | Metzger et al. | Jul 2002 | B1 |
6491726 | Pappas | Dec 2002 | B2 |
6506215 | Letot et al. | Jan 2003 | B1 |
6506216 | McCue et al. | Jan 2003 | B1 |
6709461 | O'neil et al. | Mar 2004 | B2 |
6755864 | Brack et al. | Jun 2004 | B1 |
6770078 | Bonutti | Aug 2004 | B2 |
6869448 | Tuke | Mar 2005 | B2 |
6923832 | Sharkey et al. | Aug 2005 | B1 |
6942670 | Heldreth et al. | Sep 2005 | B2 |
6953479 | Carson et al. | Oct 2005 | B2 |
6986791 | Metzger | Jan 2006 | B1 |
7025788 | Metzger et al. | Apr 2006 | B2 |
7060074 | Rosa et al. | Jun 2006 | B2 |
7083652 | McCUe et al. | Aug 2006 | B2 |
7153326 | Metzger | Dec 2006 | B1 |
7189262 | Hayes, Jr. et al. | Mar 2007 | B2 |
7264635 | Suguro | Sep 2007 | B2 |
7294149 | Hozack et al. | Nov 2007 | B2 |
7309362 | Yasuda et al. | Dec 2007 | B2 |
7445639 | Metzger et al. | Nov 2008 | B2 |
7497874 | Metzger et al. | Mar 2009 | B1 |
7513912 | Hayes, Jr. et al. | Apr 2009 | B2 |
7544211 | Rochetin | Jun 2009 | B2 |
7585328 | Haas | Sep 2009 | B2 |
7625407 | Akizuki et al. | Dec 2009 | B2 |
7628818 | Hazebrouck et al. | Dec 2009 | B2 |
7635390 | Bonutti | Dec 2009 | B1 |
7695519 | Collazo | Apr 2010 | B2 |
7850698 | Straszheim-Morley et al. | Dec 2010 | B2 |
8568486 | Wentorf et al. | Oct 2013 | B2 |
8574304 | Wentorf et al. | Nov 2013 | B2 |
8591594 | Parisi et al. | Nov 2013 | B2 |
8613775 | Wentorf et al. | Dec 2013 | B2 |
8628580 | Sanford et al. | Jan 2014 | B2 |
8758444 | Wentorf et al. | Jun 2014 | B2 |
8764840 | Sanford et al. | Jul 2014 | B2 |
9192480 | Wentorf et al. | Nov 2015 | B2 |
20010047210 | Wolf | Nov 2001 | A1 |
20020072802 | O'Neil et al. | Jun 2002 | A1 |
20020120340 | Metzger et al. | Aug 2002 | A1 |
20020161448 | Hayes, Jr. et al. | Oct 2002 | A1 |
20040034432 | Hughes et al. | Feb 2004 | A1 |
20040153066 | Coon et al. | Aug 2004 | A1 |
20040162620 | Wyss | Aug 2004 | A1 |
20040186582 | Yasuda et al. | Sep 2004 | A1 |
20040267371 | Hayes, Jr. et al. | Dec 2004 | A1 |
20050096747 | Tuttle et al. | May 2005 | A1 |
20050143831 | Justin et al. | Jun 2005 | A1 |
20050143832 | Carson | Jun 2005 | A1 |
20050209702 | Todd et al. | Sep 2005 | A1 |
20050246030 | Yao | Nov 2005 | A1 |
20050267584 | Burdulis, Jr. et al. | Dec 2005 | A1 |
20060030945 | Wright | Feb 2006 | A1 |
20060142869 | Gross | Jun 2006 | A1 |
20060161259 | Cheng et al. | Jul 2006 | A1 |
20060195195 | Burstein et al. | Aug 2006 | A1 |
20060224244 | Thomas et al. | Oct 2006 | A1 |
20070010890 | Collazo | Jan 2007 | A1 |
20070135926 | Walker | Jun 2007 | A1 |
20070198022 | Lang et al. | Aug 2007 | A1 |
20070233269 | Steines et al. | Oct 2007 | A1 |
20080021566 | Peters et al. | Jan 2008 | A1 |
20080051908 | Angibaud et al. | Feb 2008 | A1 |
20080091271 | Bonitati et al. | Apr 2008 | A1 |
20080091272 | Aram et al. | Apr 2008 | A1 |
20080091273 | Hazebrouck | Apr 2008 | A1 |
20080114462 | Guidera et al. | May 2008 | A1 |
20080167722 | Metzger et al. | Jul 2008 | A1 |
20080215156 | Duggal et al. | Sep 2008 | A1 |
20080243258 | Sancheti | Oct 2008 | A1 |
20080281426 | Fitz et al. | Nov 2008 | A1 |
20080288080 | Sancheti | Nov 2008 | A1 |
20090036992 | Tsakonas | Feb 2009 | A1 |
20090082873 | Hazebrouck et al. | Mar 2009 | A1 |
20090088862 | Thomas et al. | Apr 2009 | A1 |
20090125114 | May et al. | May 2009 | A1 |
20090149963 | Sekel | Jun 2009 | A1 |
20090149964 | May et al. | Jun 2009 | A1 |
20090204222 | Burstein et al. | Aug 2009 | A1 |
20090222103 | Fitz et al. | Sep 2009 | A1 |
20090306786 | Samuelson | Dec 2009 | A1 |
20090319047 | Walker | Dec 2009 | A1 |
20100016978 | Williams et al. | Jan 2010 | A1 |
20100016979 | Wyss et al. | Jan 2010 | A1 |
20100063594 | Hazebrouck et al. | Mar 2010 | A1 |
20100100189 | Metzger | Apr 2010 | A1 |
20100100191 | May et al. | Apr 2010 | A1 |
20100125339 | Earl et al. | May 2010 | A1 |
20100152858 | Lu et al. | Jun 2010 | A1 |
20100191341 | Byrd | Jul 2010 | A1 |
20100222890 | Barnett et al. | Sep 2010 | A1 |
20100305708 | Lang | Dec 2010 | A1 |
20100329530 | Lang et al. | Dec 2010 | A1 |
20110082559 | Hartdegen et al. | Apr 2011 | A1 |
20110087332 | Bojarski et al. | Apr 2011 | A1 |
20110144760 | Wong et al. | Jun 2011 | A1 |
20120022658 | Wentorf | Jan 2012 | A1 |
20120022659 | Wentorf | Jan 2012 | A1 |
20120022660 | Wentorf | Jan 2012 | A1 |
20120035735 | Sanford et al. | Feb 2012 | A1 |
20120035737 | Sanford | Feb 2012 | A1 |
20120101585 | Parisi et al. | Apr 2012 | A1 |
20130024001 | Wentorf et al. | Jan 2013 | A1 |
20130131820 | Wentorf et al. | May 2013 | A1 |
20140025175 | Wentorf et al. | Jan 2014 | A1 |
20140025176 | Wentorf | Jan 2014 | A1 |
20140025177 | Wentorf et al. | Jan 2014 | A1 |
20140052268 | Sanford et al. | Feb 2014 | A1 |
20140156015 | Parisi et al. | Jun 2014 | A1 |
20140257506 | Sanford et al. | Sep 2014 | A1 |
20150320564 | Parisi et al. | Nov 2015 | A1 |
Number | Date | Country |
---|---|---|
2011286306 | Oct 2014 | AU |
2190029 | Nov 1995 | CA |
687584 | Jan 1997 | CH |
2768715 | Apr 2006 | CN |
1874738 | Dec 2006 | CN |
101347359 | Jan 2009 | CN |
101401750 | Apr 2009 | CN |
101683289 | Mar 2010 | CN |
103118634 | May 2013 | CN |
103118635 | May 2013 | CN |
103118636 | May 2013 | CN |
104093380 | Oct 2014 | CN |
104203160 | Dec 2014 | CN |
0021421 | Jan 1981 | EP |
0340919 | Nov 1989 | EP |
340919 | Nov 1989 | EP |
0372811 | Jun 1990 | EP |
0306744 | Apr 1992 | EP |
0495340 | Jul 1992 | EP |
0672397 | Sep 1995 | EP |
0552950 | Sep 1996 | EP |
0536457 | Jan 1997 | EP |
0642328 | Dec 1998 | EP |
0956836 | Nov 1999 | EP |
0956836 | Nov 1999 | EP |
1097679 | May 2001 | EP |
0709074 | Dec 2002 | EP |
1327424 | Jul 2003 | EP |
1396240 | Apr 2008 | EP |
1996122 | Dec 2008 | EP |
0927009 | Jan 2009 | EP |
1555962 | Feb 2011 | EP |
2319460 | May 2011 | EP |
2324799 | May 2011 | EP |
2335654 | Jun 2011 | EP |
2347733 | Jul 2011 | EP |
0689808 | Sep 2012 | EP |
2595573 | May 2013 | EP |
2782525 | Oct 2014 | EP |
2736819 | Jan 1997 | FR |
2747914 | Oct 1997 | FR |
2778332 | Nov 1999 | FR |
2788964 | Aug 2000 | FR |
2926719 | Jul 2009 | FR |
2253147 | Sep 1992 | GB |
2345446 | Jul 2000 | GB |
62270153 | Nov 1987 | JP |
09511668 | Nov 1997 | JP |
2000245758 | Sep 2000 | JP |
2003516183 | May 2003 | JP |
2004254811 | Sep 2004 | JP |
2013535276 | Sep 2013 | JP |
2013536005 | Sep 2013 | JP |
2013536006 | Sep 2013 | JP |
2013536007 | Sep 2013 | JP |
2015504333 | Feb 2015 | JP |
2015504759 | Feb 2015 | JP |
WO-9305729 | Apr 1993 | WO |
WO-9409725 | May 1994 | WO |
WO-9514444 | Jun 1995 | WO |
WO-9530389 | Nov 1995 | WO |
WO-9535074 | Dec 1995 | WO |
WO-9934755 | Jul 1999 | WO |
WO-0141680 | Jun 2001 | WO |
WO-03099106 | Dec 2003 | WO |
WO-2005037147 | Apr 2005 | WO |
WO-2005051240 | Jun 2005 | WO |
WO-2006058057 | Jun 2006 | WO |
WO-2007108804 | Sep 2007 | WO |
WO-2007109641 | Sep 2007 | WO |
WO-2009029631 | Mar 2009 | WO |
WO-2009088238 | Jul 2009 | WO |
WO-2010008803 | Jan 2010 | WO |
WO-2010045537 | Apr 2010 | WO |
WO-2011072235 | Jun 2011 | WO |
WO-2011110865 | Sep 2011 | WO |
WO-2012018563 | Feb 2012 | WO |
WO-2012018564 | Feb 2012 | WO |
WO-2012018565 | Feb 2012 | WO |
WO-2012018566 | Feb 2012 | WO |
WO-2012018567 | Feb 2012 | WO |
WO-2012112698 | Aug 2012 | WO |
WO-2013077919 | May 2013 | WO |
WO-2013115849 | Aug 2013 | WO |
Entry |
---|
“U.S. Appl. No. 13/189,324, PTO Response to Rule 312 Communication mailed May 29, 2014”, 2 pgs. |
“U.S. Appl. No. 13/229,103, Applicant Interview Summary mailed Sep. 23, 2013”, 2 pgs. |
“U.S. Appl. No. 13/594,543, Final Office Action mailed Jul. 17, 2014”, 12 pgs. |
“U.S. Appl. No. 13/594,543, Non-Final Office Action mailed Jan. 9, 2015”, 23 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Apr. 7, 2015 to Non-Final Office Action mailed Jan. 9, 2015”, 27 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Dec. 17, 2014 to Final Office Action mailed Jul. 17, 2014”, 15 pgs. |
“U.S. Appl. No. 14/034,937, Non Final Office Action mailed Jan. 2, 2015”, 21 pgs. |
“U.S. Appl. No. 14/034,937, Response filed Mar. 30, 2015 to Non-Final Office Action”, 24 pgs. |
“U.S. Appl. No. 14/034,937, Response filed Oct. 27, 2014 to Restriction Requirement mailed Sep. 11, 2014”, 12 pgs. |
“U.S. Appl. No. 14/034,937, Restriction Requirement mailed Sep. 11, 2014”, 6 pgs. |
“U.S. Appl. No. 14/034,944, Non Final Office Action mailed Mar. 3, 2015”, 16 pgs. |
“U.S. Appl. No. 14/034,944, Response filed Dec. 15, 2014 to Restriction Requirement mailed Oct. 14, 2014”, 12 pgs. |
“U.S. Appl. No. 14/034,944, Restriction Requirement mailed Oct. 14, 2014”, 6 pgs. |
“U.S. Appl. No. 14/034,954, Final Office Action mailed Jun. 1, 2015”, 26 pgs. |
“U.S. Appl. No. 14/034,954, Non Final Office Action mailed Dec. 19, 2014”, 25 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Mar. 17, 2015 to Non Final Office Action mailed Dec. 19, 2014”, 21 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Oct. 27, 2014 to Restriction Requirement mailed Aug. 25, 2014”, 11 pgs. |
“U.S. Appl. No. 14/034,954, Restriction Requirement mailed Aug. 25, 2014”, 7 pgs. |
“U.S. Appl. No. 14/034,963, Final Office Action mailed Apr. 13, 2015”, 22 pgs. |
“U.S. Appl. No. 14/034,963, Non Final Office Action mailed Nov. 21, 2014”, 19 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Mar. 20, 2015 to Non-Final Office Action mailed Nov. 21, 2014”, 20 pgs. |
“U.S. Appl. No. 14/284,144, Non Final Office Action mailed Mar. 25, 2015”, 26 pgs. |
“U.S. Appl. No. 14/284,144, Preliminary Amendment filed May 21, 2014”, 3 pgs. |
“U.S. Appl. No. 14/284,144, Supplemental Preliminary Amendment filed Jul. 3, 2014”, 10 pgs. |
“Australian Application Serial No. 2011286306, Response filed Jun. 3, 2014 to First Examiner Report mailed Jun. 19, 2013”, 16 pgs. |
“Australian Application Serial No. 2011286307, Response filed May 21, 2014 to First Examiner Report mailed Oct. 17, 2013”, 16 pgs. |
“Australian Application Serial No. 2012341026, First Examiner Report mailed Jul. 14, 2014”, 2 pgs. |
“Australian Application Serial No. 2012341026, Response filed Nov. 21, 2014 to First Examiner Report mailed Jul. 14, 2014”, 1 pg. |
“Australian Application Serial No. 2012341026, Statement of Proposed Amendment filed Jun. 18, 2014”, 25 pgs. |
“Canadian Application Serial No. 2,856,571 Response filed Jan. 22, 2015 to Office Action mailed Jul. 22, 2014”, 24 pgs. |
“Canadian Application Serial No. 2,856,571, Office Action mailed Jul. 22, 2014”, 2 pgs. |
“Chinese Application Serial No. 201180045673.3, Office Action mailed Mar. 29, 2015”, (W/ English Translation), 6 pgs. |
“Chinese Application Serial No. 201180045681.8, Office Action mailed Jan. 22, 2015”, (W/ English Translation), 11 pgs. |
“Chinese Application Serial No. 201180045681.8, Response filed May 14, 2015 to Office Action mailed Jan. 22, 2015”, W/ English Claims, 17 pgs. |
“Chinese Application Serial No. 201180045683.7, Office Action mailed Mar. 9, 2015”, (W/ English Translation), 6 pgs. |
“Chinese Application Serial No. 201180045689.4, Office Action mailed Jan. 5, 2015”, (W/ English Translation), 4 pgs. |
“Chinese Application Serial No. 201180045689.4, Response filed May 1, 2015 to Office Action mailed Jan. 5, 2015”, W/ English Claims, 13 pgs. |
“Chinese Application Serial No. 201280071940.9, Preliminary Amendment filed Mar. 23, 2015”, W/ English Claims, 11 pgs. |
“European Application Serial No. 11738918.9, Examination Notification Art. 94(3) mailed Oct. 23, 2014”, 5 pgs. |
“European Application Serial No. 11738918.9, Preliminary Amendmentmailed Sep. 24, 2013”, 11 pgs. |
“European Application Serial No. 11738918.9, Response filed Mar. 2, 2015 to Examination Notification Art. 94(3) mailed Oct. 23, 2014”, 14 pgs. |
“European Application Serial No. 11738919.7, Examination Notification Art. 94(3) mailed Jul. 7, 2014”, 4 pgs. |
“European Application Serial No. 11738919.7, Preliminary Amendment filed Nov. 4, 2013”, 25 pgs. |
“European Application Serial No. 11738919.7, Response filed Nov. 13, 2014 to Examination Notification Art. 94(3) mailed Jul. 7, 2014”, 14 pgs. |
“European Application Serial No. 11738920.5, Preliminary Amendment Sep. 24, 2013”, 9 pgs. |
“European Application Serial No. 11758060.5, Preliminary Amendment filed Nov. 4, 2013”, 15 pgs. |
“European Application Serial No. 11815029.1, Response filed Jul. 21, 2014 Extended European Search Report mailed Dec. 10, 2013”, 15 pgs. |
“European Application Serial No. 12756058.9, Preliminary Amendment filed Apr. 20, 2015”, 12 pgs. |
“European Application Serial No. 12756869.9 Response filed Feb. 10, 2015 to Communication Pursuant to Rule 161(1) and 162 EPC mailed Jul. 31, 2014”, 14 pgs. |
“International Application Serial No. PCT/US2012/052132, International Preliminary Report on Patentability mailed Jun. 5, 2014”, 12 pgs. |
“International Application Serial No. PCT/US2012/052340, International Preliminary Report on Patentability mailed Aug. 14, 2014”, 8 pgs. |
“Japanese Application Serial No. 2013-521854, Notice of Reason for Rejection mailed Sep. 16, 2014”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2013-521854, Response filed Dec. 16, 2014 to Notice of Reason for Rejection mailed Sep. 16, 2014”, W/ English Claims, 11 pgs. |
“Japanese Application Serial No. 2013-521855, Amendment filed Jul. 22, 2014”, (W/ English Translation), 20 pgs. |
“Japanese Application Serial No. 2013-521855, Office Action mailed Mar. 24, 2015”, W/ English Translation, 8 pgs. |
“Mexican Application Serial No. MX/A/2013/000990, Office Action mailed Feb. 19, 2015”, (W/ English Translation), 4 pgs. |
“Mexican Application Serial No. MX/A/2013/000990, Response filed Apr. 29, 2015 to Office Action mailed Feb. 19, 2015”, W/ English Claims, 18 pgs. |
“Russian Application Serial No. 2013106942, Office Action mailed Apr. 16, 2015”, W/ English Translation, 5 pgs. |
“U.S. Appl. No. 13/189,324, Examiner Interview Summary mailed Jan. 13, 2014”, 4 pgs. |
“U.S. Appl. No. 13/189,324, Final Office Action mailed Jul. 16, 2013”, 19 pgs. |
“U.S. Appl. No. 13/189,324, Non Final Office Action mailed Dec. 11, 2012”, 19 pgs. |
“U.S. Appl. No. 13/189,324, Notice of Allowance mailed Feb. 20, 2014”, 8 pgs. |
“U.S. Appl. No. 13/189,324, Response filed Jan. 15, 2014 to Final Office Action dated Jul. 16, 2013”, 23 pgs. |
“U.S. Appl. No. 13/189,324, Response filed Jun. 10, 2013 to Non Final Office Action mailed Dec. 11, 2012”, 24 pgs. |
“U.S. Appl. No. 13/189,328, Non Final Office Action mailed Mar. 19, 2013”, 10 pgs. |
“U.S. Appl. No. 13/189,328, Notice of Allowance mailed Oct. 8, 2013”, 12 pgs. |
“U.S. Appl. No. 13/189,328, PTO Response to 312 Amendment mailed Dec. 13, 2013”, 2 pgs. |
“U.S. Appl. No. 13/189,328, Response filed Jan. 10, 2013 to Restriction Requirement mailed Dec. 10, 2012”, 9 pgs. |
“U.S. Appl. No. 13/189,328, Response filed Jul. 18, 2013 to Non Final Office Action mailed Mar. 19, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,328, Restriction Requirement mailed Dec. 10, 2012”, 6 pgs. |
“U.S. Appl. No. 13/189,336, Notice of Allowance mailed Sep. 13, 2013”, 30 pgs. |
“U.S. Appl. No. 13/189,336, PTO Response to 312 Amendment mailed Nov. 25, 2013”, 2 pgs. |
“U.S. Appl. No. 13/189,336, Response filed Apr. 15, 2013 to Restriction Requirement mailed Jan. 30, 2013”, 21 pgs. |
“U.S. Appl. No. 13/189,336, Response filed Jul. 17, 2013 to Restriction Requirement mailed Jun. 17, 2013”, 20 pgs. |
“U.S. Appl. No. 13/189,336, Restriction Requirement mailed Jan. 30, 2013”, 5 pgs. |
“U.S. Appl. No. 13/189,336, Restriction Requirement mailed Jun. 17, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,338, Notice of Allowance mailed Sep. 23, 2013”, 23 pgs. |
“U.S. Appl. No. 13/189,338, Response filed Apr. 15, 2013 to Restriction Requirement mailed Feb. 14, 2013”, 18 pgs. |
“U.S. Appl. No. 13/189,338, Response filed Jul. 17, 2013 to Restriction Requirement mailed Jun. 17, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,338, Restriction Requirement mailed Feb. 14, 2013”, 5 pgs. |
“U.S. Appl. No. 13/189,338, Restriction Requirement mailed Jun. 17, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,339, Notice of Allowance mailed Sep. 20, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,339, Response filed Apr. 15, 2013 to Restriction Requirement mailed Mar. 6, 2013”, 11 pgs. |
“U.S. Appl. No. 13/189,339, Response filed Jul. 17, 2013 to Restriction Requirement mailed Jun. 17, 2013”, 10 pgs. |
“U.S. Appl. No. 13/189,339, Restriction Requirement mailed Mar. 6, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,339, Restriction Requirement mailed Jun. 17, 2013”, 7 pgs. |
“U.S. Appl. No. 13/229,103, Examiner Interview Summary mailed Sep. 13, 2013”, 3 pgs. |
“U.S. Appl. No. 13/229,103, Non Final Office Action mailed Apr. 1, 2013”, 18 pgs. |
“U.S. Appl. No. 13/229,103, Notice of Allowance mailed Sep. 18, 2013”, 9 pgs. |
“U.S. Appl. No. 13/229,103, Response filed Jul. 1, 2013 to Non Final Office Action mailed Apr. 1, 2013”, 19 pgs. |
“U.S. Appl. No. 13/229,103, Supplemental Notice of Allowability mailed Oct. 18, 2013”, 2 pgs. |
“U.S. Appl. No. 13/593,339, Non Final Office Action mailed Oct. 4, 2013”, 7 pgs. |
“U.S. Appl. No. 13/593,339, Notice of Allowance mailed Feb. 14, 2014”, 9 pgs. |
“U.S. Appl. No. 13/593,339, Preliminary Amendment filed Aug. 23, 2012”, 6 pgs. |
“U.S. Appl. No. 13/593,339, Response filed Jan. 31, 2014 to Non-Final Office Action dated Oct. 4, 2013”, 19 pgs. |
“U.S. Appl. No. 13/593,339, Response filed Aug. 30, 2013 to Restriction Requirement mailed Aug. 1, 2013”, 14 pgs. |
“U.S. Appl. No. 13/593,339, Restriction Requirement mailed Aug. 1, 2013”, 5 pgs. |
“U.S. Appl. No. 13/593,339, Supplemental Notice of Allowability mailed Mar. 31, 2014”, 2 pgs. |
“U.S. Appl. No. 13/594,543, Non Final Office Action mailed Dec. 26, 2013”, 15 pgs. |
“U.S. Appl. No. 13/594,543, Preliminary Amendment filed Aug. 24, 2012”, 4 pgs. |
“U.S. Appl. No. 13/594,543, Response filed May 7, 2014 to Non-Final office Action dated Dec. 26, 2013”, 17 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Oct. 11, 2013 to Restriction Requirement mailed Sep. 12, 2013”, 8 pgs. |
“U.S. Appl. No. 13/594,543, Restriction Requirement mailed Sep. 12, 2013”, 5 pgs. |
“U.S. Appl. No. 14/034,937, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,937, Supplemental Preliminary Amendment filed Oct. 24, 2013”, 11 pgs. |
“U.S. Appl. No. 14/034,944, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,944, Supplemental Preliminary Amendment filed Oct. 24, 2013”, 11 pgs. |
“U.S. Appl. No. 14/034,954, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,954, Supplemental Preliminary Amendment filed Oct. 25, 2013”, 8 pgs. |
“U.S. Appl. No. 14/034,963, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/063,593, Preliminary Amendment filed Oct. 25, 2013”, 3 pgs. |
“Australian Application Serial No. 2011286306, First Examiner Report mailed Jun. 19, 2013”, 4 pgs. |
“Australian Application Serial No. 2011286307, First Examiner Report mailed Oct. 17, 2013”, 2 pgs. |
“Australian Application Serial No. 2011286308, First Examiner Report mailed Jun. 21, 2013”, 4 pgs. |
“Australian Application Serial No. 2011286309, First Examiner Report mailed Jun. 21, 2013”, 3 pgs. |
“Bi-Cruciate Stabilized Knee System”, Design Rationale, Smith & Nephew Journal, (2006), 20 pgs. |
“European Application Serial No. 11815029.1, Extended European Search Report mailed Dec. 10, 2013”, 8 pgs. |
“Extramedullary/Intramedullary Tibial Resector: Surgical Technique”, Nexgen Complete Knee Solution, Zimmer, Inc. 97/5997-02 Rev 1, (2000, 2002), 25 pgs. |
“Extramedullary/Intramedullary Tibial Resector: Surgical Technique”, Nexgen Complete Knee Solution, Zimmer, Inc., (2000, 2008, 2009), 28 pgs. |
“Gender Solutions Natural-Knee Flex System”, Zimmer, Inc., (2007, 2009), 6 pgs. |
“International Application Serial No. PCT/US2011/045077, International Preliminary Report on Patentability mailed Jul. 5, 2012”, 23 pgs. |
“International Application Serial No. PCT/US2011/045077, International Search Report and Written Opinion mailed Jan. 9, 2012”, 15 pgs. |
“International Application Serial No. PCT/US2011/045078, International Preliminary Report on Patentability mailed Feb. 7, 2013”, 11 pgs. |
“International Application Serial No. PCT/US2011/045078, International Search Report and Written Opinion mailed Jan. 9, 2012”, 14 pgs. |
“International Application Serial No. PCT/US2011/045080, International Preliminary Report on Patentability mailed Feb. 7, 2013”, 13 pgs. |
“International Application Serial No. PCT/US2011/045080, International Search Report mailed Jan. 9, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2011/045080, Written Opinion mailed Jan. 9, 2012”, 11 pgs. |
“International Application Serial No. PCT/US2011/045082, International Preliminary Report on Patentability mailed Feb. 7, 2013”, 11 pgs. |
“International Application Serial No. PCT/US2011/045082, International Search Report mailed Jan. 9, 2012”, 5 pgs. |
“International Application Serial No. PCT/US2011/045082, Written Opinion mailed Jan. 9, 2012”, 10 pgs. |
“International Application Serial No. PCT/US2011/045083, International Preliminary Report on Patentability mailed Feb. 7, 2013”, 8 pgs. |
“International Application Serial No. PCT/US2011/045083, International Search Report mailed Dec. 7, 2011”, 2 pgs. |
“International Application Serial No. PCT/US2011/045083, Written Opinion mailed Dec. 7, 2011”, 6 pgs. |
“International Application Serial No. PCT/US2011/051021, International Preliminary Report on Patentability mailed Mar. 21, 2013”, 8 pgs. |
“International Application Serial No. PCT/US2011/051021, International Search Report mailed Nov. 23, 2011”, 12 pgs. |
“International Application Serial No. PCT/US2011/051021, Written Opinion mailed Nov. 23, 2011”, 7 pgs. |
“International Application Serial No. PCT/US2012/052132, International Search Report mailed Jan. 10, 2013”, 5 pgs. |
“International Application Serial No. PCT/US2012/052132, Invitation to Pay Additional Fees and Partial Search Report mailed Nov. 15, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2012/052132, Written Opinion mailed Jan. 10, 2013”, 10 pgs. |
“International Application Serial No. PCT/US2012/052340, Search Report mailed Oct. 12, 2012”, 4 pgs. |
“International Application Serial No. PCT/US2012/052340, Written Opinion mailed Oct. 12, 2012”, 6 pgs. |
“LPS-Flex Fixed Bearing Knee: Surgical Technique”, Zimmer, Inc., (2004, 2007, 2008), 16 pgs. |
“NexGen Trabecular Metal Modular Plates”, Zimmer Inc., (2007), 19 pgs. |
“South African Application Serial No. 2013/01327, Amendment filed Apr. 24, 2014”, 4 pgs. |
“South African Application Serial No. 2013/01328, Amendment filed Apr. 24, 2014”, 4 pgs. |
“Surgical Technique for the CR-Flex Fixed Bearing Knee”, NexGen Complete Knee Solution, Zimmer, Inc., (2003), 22 pgs. |
“Tibial Baseplate: Pocket Guide (United States Version)”, Zimmer, Inc.,, (2009), 17 pgs. |
“Trabecular Metal Monoblock Tibial Components”, Zimmer, Inc., (2007), 4 pgs. |
“Trabecular Metal Monoblock Tibial Components Surgical Technique Addendum”, Nexgen Zimmer, Inc., (2005, 2007), 12 pgs. |
“Trabecular Metal Tibial Tray: Surgical Technique”, NexGen Zimmer, Inc., (2007, 2009), 16 pgs. |
Annayappa, Ramesh, et al., “Tibial Prosthesis”, U.S. Appl. No. 13/189,324, filed Jul. 22, 2011, 50 pgs. |
Annayappa, Ramesh, “Tibial Prosthesis”, U.S. Appl. No. 13/189,328, filed Jul. 22, 2011, 82 pgs. |
Ding, M., et al., “Age-related variations in the microstructure of human tibial cancellous bone”, Journal of Orthopaedic Research, 20(3), (2002), 615-621. |
Ding, M., et al., “Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis”, Journal of Bone & Joint Surgery (British), 85-B(6), (Aug. 2003), 906-912. |
Doyle, et al., “Comparative Analysis of Human Trabecular Bone and Polyurethane Foam”, Purdue University., 1 pg. |
Dunbar, M. J., et al., “Fixation of a Trabecular Metal Knee Arthroplasty Component: A Prospective Randomized Study”, The Journal of Bone & Joint Surgery (American), vol. 91-A(7), (Jul. 2009), 1578-1586. |
Edwards, Andrew, et al., “The Attachments of the Fiber Bundles of the Posterior Cruciate ligament: An Anatomic Study”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 23, No. 3, (Mar. 2008), 284-290. |
Hvid, Ivan, et al., “Trabecular bone Strength Patterns at the Proximal Tibial Epiphysis”, Journal of Orthopaedic Research, vol. 3, No. 4, (1985), 464-472. |
Klostermann, et al., “Distribution of bone mineral density with age and gender in the proximal tibia”, Clinical Biomechanics 19, 376-376. |
Lorenz, Stephan, et al., “Radiological evaluation of the anterolateral and posteromedial bundle insertion sites of the posterior cruciate ligament”, Knee Surg Sports Traumatol Arthosc, vol. 17, (2009), 683-690. |
Moorman, Claude, et al., “Tibial Insertion of the Posterior Cruciate Ligament: A Sagittal Plane Analysis Using Gross, Histologic, and Radiographic Methods”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 24, No. 3, (Mar. 2008), 269-275. |
Parisi, Raymond C, “Motion Facilitating Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/229,103, filed Sep. 9, 2011, 46 pgs. |
Stilling, et al., “Superior fixation of pegged trabecular metal over screw-fixed pegged porous titanium fiber mesh”, Acta Orthopaedica., (2011), 177-186. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,338, filed Jul. 22, 2011, 58 pgs. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,339, filed Jul. 22, 2011, 52 pgs. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,336, filed Jul. 22, 2011, 60 pgs. |
“Chinese Application Serial No. 201180045673.3, Response filed Oct. 27, 2015 to Office Action mailed Aug. 12, 2015”, W/ English Claims, 9 pgs. |
“Chinese Application Serial No. 201280067473.2, Office Action mailed Nov. 20, 2015”, W/ English Claims, 7 pgs. |
“European Application Serial No. 12756869.9, Response filed Nov. 12, 2015 to Examination Notification Art. 94(3) mailed Jul. 2, 2015”, 28 pgs. |
“Russian Application Serial No. 2013106943, Response filed Oct. 30, 2015 to Office Action mailed Jan. 7, 2015”, W/ English Claims, 21 pgs. |
“U.S. Appl. No. 13/594,543, Final Office Action mailed Nov. 20, 2015”, 28 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Sep. 21, 2015 to Non-Final Office Action mailed Jun. 19, 2015”, 25 pgs. |
“U.S. Appl. No. 14/034,954, Notice of Allowance mailed Nov. 20, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Sep. 30, 2015 to Non Final Office Action mailed Jul. 1, 2015”, 14 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Nov. 20, 2015 to Final Office Action mailed Oct. 13, 2015”, 12 pgs. |
“U.S. Appl. No. 14/063,593, Restriction Requirement mailed Nov. 6, 2015”, 6 pgs. |
“U.S. Appl. No. 14/284,144, Notice of Allowance mailed Oct. 29, 2015”, 8 pgs. |
“U.S. Appl. No. 14/284,144, Response filed Oct. 9, 2015 to Final Office Action mailed Aug. 7, 2015”, 13 pgs. |
Number | Date | Country | |
---|---|---|---|
20140249641 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
61621369 | Apr 2012 | US | |
61594030 | Feb 2012 | US | |
61592571 | Jan 2012 | US | |
61562133 | Nov 2011 | US | |
61621374 | Apr 2012 | US | |
61592574 | Jan 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13593339 | Aug 2012 | US |
Child | 14278805 | US |